FDA Pushes to Reduce Single-Source Generics, Increase Biosimilars

By Ed Lamb, DrugPatentWatch writer Under a new commissioner dedicated to bolstering competition to reduce prices, the agency is redoing a raft of rules and guidances to speed ANDA approvals…

The post FDA Pushes to Reduce Single-Source Generics, Increase Biosimilars appeared first on DrugPatentWatch.

Comments are closed.